Translational Cancer Research Associate (12-month)

University Of Bradford; Aberford; Vor Ort; GBP 36.000 - 39.000; Vollzeit

Benefits dieser Stelle

25 days holiday

Wellcome Accelerator Award

Zusammenfassung

University of Bradford invites applications for a Research Associate in the Institute of Health and Social Care, part of the Institute of Cancer Therapeutics (ICT). You will evaluate hypoxia-selective cancer therapeutics using 2D and 3D models, and explore combinations with chemotherapy and radiotherapy.

The role demands an MSc/PhD in a relevant field and experience in mammalian cell culture, molecular biology, flow cytometry, and LC-MS studies.

Qualifikationen

• MSc or PhD in cancer biology, pharmacology, molecular biology, biomedical sciences or a related discipline.
• Experience in mammalian cell culture and in vitro biological assays.
• Ability to design, conduct and analyse laboratory experiments and interpret scientific data.

Aufgaben

• Evaluate hypoxia-selective therapeutics using 2D and 3D cancer models, including in combination with chemotherapy and radiotherapy.
• Investigate mechanisms of action and therapeutic response using molecular and cellular biology, flow cytometry and gene-editing approaches.
• Support translational drug development through LC-MS-based studies of drug activation, stability and pharmacokinetics, alongside data analysis and dissemination of findings.

Kenntnisse

Mammalian cell culture

Molecular biology

Flow cytometry

Data analysis

Gene editing

Ausbildung

MSc or PhD in cancer biology or related field

Tools

LC-MS instruments

Flow cytometer

Jobbeschreibung

University of Bradford invites applications for a Research Associate in the Institute of Health and Social Care, part of the Institute of Cancer Therapeutics (ICT). You will evaluate hypoxia-selective cancer therapeutics using 2D and 3D models, and explore combinations with chemotherapy and radiotherapy.

The role demands an MSc/PhD in a relevant field and experience in mammalian cell culture, molecular biology, flow cytometry, and LC-MS studies.